elixia asia sales $200 mill within 3 yrs, page-45

Music to my ears.
That's how I describe the line 'i have been looking for' in the CCZ report.

'....Watson's management have already indicated a strong appetite to support and promote the elixia range.'

and

'....if Watson gets behind the products in Asia (which they are very keen to do) they alone could generate multiples of our current revenue forecast.'

For some time now, I have been wondering (and concerned) how elixia marketing will be funded in Asia. This is the first indication that Watson's will be the catalyst in elixia promotion.
Probably part of the deal nutted out, that as part of their profit share, they need to take care of marketing.

Imagine mass marketing by Watson's re: elixia. Hold on to your hats.

Good report in general. 33c forecast purely on oxy and elixia.
One day I would like someone to include the other 20 pipeline products.
Is that how they rate mining companies ? We have calculated how many barrels at this well, but left out the aluminium and gold at the other sites ??

Great to see Myer's going great guns and going to expand into 67 stores, especially that the minimum sales target were easily met.

So it won't be long
Australia
Singapore
HongKong
India
Korea
USA
China


Philsim - 15% market share by 2020 - you know my thoughts. Laughable.
They just listed significant adverse reactions to tablets and a list of the immense benefits of the patch and hit a peak of 15% in 10 years.
I wouldn't be surprised if the oxypatch makes the FDA call for a significant reduction of oxycodone tablet production.


The story keeps getting better.